finanzen.net
12.10.2018 00:00
Bewerten
(0)

Global Antidepressant Drugs Market Forecast 2018-2024: Key Players are Novartis, Allergan, Elli Lilly and Co, AstraZeneca, GSK, Otsuka and Johnson & Johnson

DRUCKEN

DUBLIN, Oct 11, 2018 /PRNewswire/ --

The "Global Antidepressant Drugs Market Forecast up to 2018-2024" report has been added to ResearchAndMarkets.com's offering.

Depression is a serious mental illness affecting more than 350 million people globally. This is also known as major depression disorder or unipolar depression. According to a report by the Psychiatric Association, nearly 14.8 million adults in the US are suffering from depression. An ageing population and the increasing prevalence of depression are the primary factors driving the global antidepressant drugs market growth. Supportive initiatives from the government and other organizations and increasing clinical trials will provide an opportunity for the market growth in the future.

At the global level, over 300 million people are estimated to suffer from depression, which is equivalent to 4.4% of the world's total population. Only less than 10% of the affected people are treated although there is the availability of branded and effective treatments for depression. The challenges for effective care include lack of capitals, unavailability of qualified health-care providers, and public stigma associated with mental disorders. Along with these, imprecise assessment of the condition is also a challenge faced globally.

The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the antidepressant drugs market, followed by Europe, Asia Pacific, and Rest of the World. North America alone occupies more than 30% of the market, with a significant contribution from the US to market growth.

Based on the drug class, the market is segmented into selective serotonin reuptake inhibitors (SSRIs), norepinephrine-dopamine reuptake inhibitors (NDRI), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and others. SSRIs are the most attractive drug in the market, owing to the highly effective treatment of depression and anxiety.


Key Players in this market are

  • Novartis AG
  • Allergan Inc
  • Elli Lilly and Company
  • AstraZeneca plc
  • GSK
  • Otsuka Holdings Co., Ltd
  • Johnson & Johnson

The other prominent players include

  • Pfizer
  • Shionogi & Co. Ltd
  • Abbott Laboratories
  • Takeda Pharmaceutical Co., Ltd.
  • H. Lundbeck A/S

Market Dynamics

Drivers

  • Increasing aging population
  • Increasing prevalence of Depression

Opportunities

  • Government Initiatives
  • Exhaustive Pipeline and Increasing Clinical Trials

Restraints

  • Complex drug development process
  • Adverse effects of antidepressant drugs

Key Topics Covered:
 
1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outline

5 Market Characteristics

6 Drug Class: Market Size and Analysis

7 Regions: Market Size and Analysis

8 Competitive Landscape

9 Vendor Profiles

10 Companies to Watch for

For more information about this report visit https://www.researchandmarkets.com/research/9ztv7c/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

Cision View original content:http://www.prnewswire.com/news-releases/global-antidepressant-drugs-market-forecast-2018-2024-key-players-are-novartis-allergan-elli-lilly-and-co-astrazeneca-gsk-otsuka-and-johnson--johnson-300729633.html

SOURCE Research and Markets

+ 13% pro Jahr - So erzielen Sie höhere Renditen

Wie können Anleger mehr Rendite aus ihrem Depot holen ohne dabei höhere Risiken einzugehen? Im Online-Seminar erklärt der Finanz­mathematiker Michael Schnoor, wie es funktioniert.
Hier informieren und kostenlos anmelden
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Fünf deutsche Internet-Aktien, die Sie kennen sollten!

Das Gute liegt oft so nah. Heimische Internet-Unternehmen rollen den Markt auf. Im neuen Anlegermagazin erwartet Sie ein Special über deutsche Internet-Aktien, die Sie kennen sollten.
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht tiefer aus dem Handel -- Dow nach Fed-Protokoll leichter -- Elon Musk kauft Tesla-Aktien -- Fresenius pessimistischer für Gesamtjahr -- Netflix schlägt Erwartungen -- IBM, FMC, Roche im Fokus

Investoren wollen Sanierung von Steinhoff nicht mit Klagen stören. "Boomwahrscheinlichkeit" in Deutschland bei knapp 35 Prozent. RIB Software beschließt kleinen Aktienrückkauf. EU genehmigt Verkauf von Praxair-Geschäften nach Japan. BVB-Aktie im Aufwind: 17-Jahres-Hoch. Experten rechnen mit anhaltend steigenden Anleiherenditen.

Die 5 beliebtesten Top-Rankings

Die weltweit größten Smartphone-Hersteller
Der Worldwide Quarterly Mobile Phone Tracker
So viel erhalten Bundesliga-Clubs durch Trikotsponsoring
Das Trikotsponsoring der Bundesliga 2018/2019
In diesen Städten leben die Superreichen
Welche Stadt ist besonders beliebt?
Automobilneuheiten-Messe
Neue Studien und Serienfahrzeuge
Best Global Brands 2018
Die Top 20 der wertvollsten Marken weltweit
mehr Top Rankings

Umfrage

Glauben Sie, dass Angela Merkel Anfang Dezember auf dem Parteitag der CDU als Parteichefin wiedergewählt wird?

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Lufthansa AG823212
Aurora Cannabis IncA12GS7
Fresenius Medical Care AG & Co. KGaA (FMC) St.578580
Netflix Inc.552484
Amazon906866
Wirecard AG747206
Fresenius SE & Co. KGaA (St.)578560
Deutsche Bank AG514000
Daimler AG710000
EVOTEC AG566480
Apple Inc.865985
TeslaA1CX3T
Deutsche Telekom AG555750
BVB (Borussia Dortmund)549309
BASFBASF11